Similar articles

• [Therapy of heart failure after myocardial infarction. With eplerenone a new course].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2004 Oct 21;146(43):58-9. MMW Fortschr Med. 2004. PMID: 15559524 German. No abstract available.
• Treatment guidelines for heart failure stress multidrug approach.

  Morey SS. Morey SS. Am Fam Physician. 1999 Jun;59(11):3265-6. Am Fam Physician. 1999. PMID: 10392599 No abstract available.
• AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.

  Azadpour M, Lamas GA. Azadpour M, et al. Expert Rev Cardiovasc Ther. 2004 Nov;2(6):891-902. doi: 10.1586/14779072.2.6.891. Expert Rev Cardiovasc Ther. 2004. PMID: 15500434 Review.
• [Why heart failure clinics?].

  Hülsmann M, Pacher R. Hülsmann M, et al. Wien Klin Wochenschr. 2002 Oct 31;114(19-20):819-21. Wien Klin Wochenschr. 2002. PMID: 12503472 German. No abstract available.
• [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].

  Gronda E, Mangiavacchi M, Andreuzzi B, Municinò A. Gronda E, et al. Ital Heart J Suppl. 2001 Dec;2(12):1278-83. Ital Heart J Suppl. 2001. PMID: 11838348 Review. Italian.